We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Topical Lice Lotion Does Away with Combing

By HospiMedica International staff writers
Posted on 20 Feb 2012
A new lotion for the treatment of head lice works by binding to invertebrate nerve and muscle cells, killing the lice without need for subsequent nit combing.

Sklice is a new topical formulation of ivermectin, an antiparasitic that has been used orally for more than 20 years to control onchocerciasis in humans. More...
Ivermectin was developed from a soil bacterium that produces avermectins, a family of compounds shown to bind selectively and with high affinity to certain ion channels present in invertebrate nerve and muscle cells, but not in mammals. Widespread oral use of ivermectin began in 1987, and to date more than one billion treatments of ivermectin tablets have been administered to help alleviate the suffering caused by onchocerciasis and other parasitic conditions.

Sklice lotion, a product of Sanofi (Paris, Franc), was approved by the US Food and drug Administration (FDA) based on the results of two randomized, double-blind phase 3 clinical trials that compared Sklice with a placebo in 781 patients from the United States who were six months of age and older. Significantly more subjects in the Sklice group were louse-free, Sklice was well-tolerated, and the majority of Sklice-treated patients were lice-free without any nit combing after two weeks. Less than 1% of patients experienced adverse events, which included conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin, and skin-burning sensation.

“The approval of Sklice Lotion provides physicians and parents with a new treatment option for head lice, a condition that is notoriously frustrating to treat,” said Kenneth Guito, general manager of Sanofi-Topaz. “Through a unique mode of action, Sklice Lotion resolves most head lice infestations in one application, and is very well-tolerated.”

Head lice are wingless parasites that live close to the human scalp and feed on human blood. They move by crawling and are mainly spread by head-to-head contact, most commonly among preschool children attending childcare, elementary schoolchildren, and the household members of infested children. Infrequently, transmission may also occur by contact with items recently used by an infested person, such as clothing, brushes, towels, or pillows. Although head lice infestation is not related to cleanliness, patients experience social stigma, embarrassment, and low self-esteem. The process of eradicating lice and their nits can also be stressful, tedious, and costly.

Related Links:

Sanofi



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Blood Gas Analyzer
i-Check200
New
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.